Back to search
Late-infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Late-infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Late-infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a phase I/II randomized, masked, clinical trial to determine the safety and efficacy of intravitreal administration of cerliponase alfa.
The purpose of this study is to gather information on the possible symptoms that patients with atypical neuronal ceroid lipofuscinosis type 2 (also known as aTP…